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We	 examined	 the	 effects	 of	 an	 aqueous	 extract	 from	 seeds	 of	 Securigera securidaca L.	 
(S. s.),	a	plant	used	in	folk	medicine,	on	experimentally	induced	pain	in	balb­c	mice.	The	tail­
flick	test	(somatic	pain	evoked	by	thermonociceptive	stimulation)	and	writhing	test	(visceral	
pain	after	i.p.	injections	of	acetic	acid)	were	used.	Three	doses	of	the	extract	(85,	170,	340	mg	 
of	 dry	 substance	 per	 1	 kg	 body	 mass)	 were	 i.p.	 injected	 before	 the	 tests.	 Significant	
antinociception	 effects	 were	 observed	 in	 both	 tests;	 a	 dose	 of	 170	 mg/kg	 appeared	 to	 be	
optimum.	Antinociceptive	effects	of	the	S. s.	extract	were	comparable	with	those	of	1	mg/kg	 
morphine.	 Naloxone,	 metoclopramide,	 ondancetron,	 and	 scopolamine	 (antagonists	 of	
opioid,	dopamine,	serotonin,	and	cholinergic	receptors,	respectively)	completely	eliminated	
antinociceptive	effects	of	the	S. s.	extract	in	the	tail­flick	test;	the	effects	of	these	antagonists	
were	not	so	clear	in	the	writhing	test.	The	mechanisms	of	analgesic	actions	of	the	S. s.	extract	
are	discussed;	the	respective	effects	are	probably	related	(at	least	partly)	to	the	presence	of	
flavonoids	in	this	extract.	Further	investigations	are	necessary	for	adequate	interpretation	of	
the	above	mechanisms.	
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INTRODUCTION
A	 number	 of	 novel	 analgesic	 drugs	 have	 been	
proposed	 within	 recent	 years.	 Better	 efficacy	 and	
fewer	 side	 effects	 are,	 naturally,	 expected	 from	
such	 pharmaceutical	 agents.	 Many	 researchers	 and	
pharmaceutical	 companies	 focus	 at	 present	 their	
attention	on	plant	products	 for	 finding	new	analgesic	
means	for	clinical	application	[1].	
Securigera securidaca L.	 (S. s.)	 called	 “gandeh­
talkhe”	in	the	Iranian	literature	(“goat	pea”	in	English)	
is	 a	 plant	 from	 the	 Papillionaceae	 family	 [2].	 This	
plant	 has	 for	 a	 long	 time	 been	 used	 in	 Iranian	 folk	
medicine	 [3­5].	According	 to	 the	 respective	 studies,	
its	 seed	 extract	 demonstrates	 various	 activities,	 in	
particular	hypokalemic,	diuretic,	antiepileptic,	marked	
chronotropic,	 and	 hypoglycemic.	The	 hydroalcoholic	
extract	 of	 this	 plant	 was	 reported	 to	 exert	 a	
hypolipidemic	 effect	 [6].	 The	 antioxidant	 activity	 of	
this	extract	has	also	been	assessed	[7].	
Phytochemical	researches	showed	that	many	poten­
tially	active	components,	 in	particular	flavonoids,	al­
kaloids,	tannins,	and	saponins,	are	present	in	the	S. s.	 
seed	 extract	 [5].	 As	 was	 found,	 various	 flavonoids	
provide	 significant	 antinociception	 effects [1,	 8­10].	
Flavonoids	 can	 inhibit	 enzymes	 involved	 in	metabo­
lism	of	arachidonic	acid,	and	this	suppresses	pain	and	
inflammation	[10,	11].	
Thus,	there	are	some	components	in	the	S. s.	extract	
that	possess	analgesic	effects.	At	the	same	time,	to	our	
knowledge,	integral	antinociceptive	effects	of	the	S. s.	 
have	 not	 been	 directly	 documented.	 Using	 standard	
behavioral	tests,	we	examined antinociceptive	effects	
of the S. s.	aqueous	extract	 in	male	mice	and	tried	to	
estimate	possible	neurochemical	mechanisms	of	such	
effects.
METHODS
Animals. Adult	 balb­c	 male	 mice	 weighing	 20­40	 g	 
were	 housed	 in	 an	 animal	 house	 at	 the	 Hamadan	
University	 of	 Medical	 Sciences.	 Temperature	 and	
humidity	 were	 controlled	 and	 maintained	 constant	
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(20­25°C,	 45­65%).	 All	 animals	 had	 access	 to	 food	
pellets	 and	 tap	water	at libitum	 and	were	maintained	
under	 a	 12/12	 h	 light/dark	 cycle.	 Experiments	 were	
performed	 at	 9.00	 to	 13.00	 each	 day	 and	 conformed	
to	the	Guide	for	Care	and	Use	of	Laboratory	Animals	
published	 by	 the	United	States	National	 Institutes	 of	
Health	(NIH	Publication	No.	85­23,	revised	1985).
Preparation of the Extract. The S. s.	 plants	were	
gathered	 from	 the	 campus	 of	 the	 Herbal	 Garden	 in	
Hamedan	 (Iran),	 identified,	 and	 authenticated.	 The	
seeds	of	the	plant	were	dispersed	and	added	to	hot	water	
lower	than	the	boiling	point	for	about	20	min,	and	the	
mixture	was	filtered.	The	filtrate	was	freeze­dried.	
Tail-Flick Test. Acute	 somatic	 pain	 was	 induced	
via	 thermonociceptive	stimulation	by	 focusing	an	 in­
frared	beam	on	the	middle	part	of	the	tail;	a	tail­flick	
unit	was	 used	 [12].	Mice	were	 held	 in	 the	 restrainer	
with	their	tail	out	and	habituated	for	2	min	to	the	en­
vironment.	The	latency	of	flicking	the	tail	(TFL)	was	
measured	three	times	for	each	mouse	with	2­min­long	
rests.	The	cut­off	time	for	preventing	tissue	injury	was	
10	 sec.	Acute	 antinociception	 effects	were	 estimated	
by	 comparison	 of	 the	 data	 obtained	 before	 and	 after	
injections	(see	below).
Writhing (Acetic Acid) Test.	Acetic	acid	(6%)	i.p.	
injections	 (10	ml/kg)	were	 used	 for	 the	 induction	 of	
visceral	 pain	 manifested	 in	 abdominal	 contractions	
[13].	The	animals	of	experimental	groups	were	adapted	
at	least	30	min	to	the	test	cage.	Abdominal	contractions	
followed	by	hindlimb	extensions	were	counted	for	30	
min	 (involving	 three	 10­min­long	 periods)	 starting	
just	after	acetic	acid	injection.	
Drugs. Morphine	 sulfate	 (Daroupakhsh,	 Iran),	 as	
a	 generally	 used	 pain­suppressing	 drug,	 naloxone	
(Toliddaru,	 Iran)	 as	 an	 opioid	 receptor	 antagonist,	
metoclopramide	(Tehran	Cheime,	Iran)	as	a	dopamine	
receptor	antagonist,	ondansetron	(Tehran	Cheime,	Iran)	
as	 a	 serotonin	 receptor	 antagonist,	 and	 scopolamine	
(Sigma,	 India)	 as	 a	 cholinergic	 receptor	 antagonist	
were	applied	in	the	tests.	The	S. s.	seed	aqueous	extract	
was	injected	in	three	different	doses	(85,	170,	and	340	
mg/kg	of	the	dry	substance).
Experimental Groups. Nine	animal	groups	(n	=	7	 
in	 each)	 were	 used	 in	 the	 tests.	 Three	 groups	 (2­4)	
received	 injections	 of	 the	 S. s.	 extract	 in	 the	 above­
mentioned	three	doses.	Group	5	(Morph)	was	injected	
with	1	mg/kg	morphine	sulfate.	Groups	6­9	(Nal+S. s.	
170,	Ond+S. s.	170,	Met+S. s.	170,	and	Scop+S. s.	170)	
received	 the	mentioned	 drugs	 (Nal,	 0.4	mg/kg;	Ond,	
0.5	 mg/kg;	 Met,	 1.0	 mg/kg,	 and	 Scop,	 1.0	 mg/kg);	 
10	 min	 later,	 the	 extract	 (170	 mg/kg)	 was	 injected.	
The	Morph	group	was	preliminarily	injected	with	2%	
saline,	and	the	same	was	done	in	the	S. s.	groups.	The	
control	group	1	received	2%	saline	in	both	injections.	
Tests	were	begun	in	all	groups	15	min	after	the	second	
injection.	All	drugs,	extract,	and	saline	were	 injected	
i.p.	in	a	10	ml/kg	volume.	
Statistical Analysis. The	 Student’s	 paired	 t­test	
was	 used	 for	 comparing	 the	 baseline	 and	 post­
injection	 TFL	 values.	 Statistical	 comparisons	 among	
experimental	 groups	 were	 performed	 by	 one­way	
analysis	of	variance	(ANOVA)	followed	by	the	Tukey	
test.	The	level	P	<	0.05	was	taken	as	significant.	Data	
are	presented	below	as	means	±	s.e.m.
RESULTS
There	 were	 no	 significant	 intergroup	 differences	
between	the	TFL	values	before	the	injections	(baseline	
TFLs).	 The S. s.	 extract	 demonstrated	 significant	
antinociceptive	 effects	 in	 the	 tail­flick	 test	 (Fig.	 1).	
The	 85	 mg/kg	 dose	 increased	 the	 mean	 TFL	 very	
slightly	 but	 significantly.	 The	 170	 mg/kg	 dose	 of	
the S. s.	 extract	 was	 found	 to	 be	 most	 effective;	 it	
increased	the	mean	TFL	more	than	two	times,	but	with	
high	interindividual	variability.	The	highest	dose	used	 
(340	mg/kg)	 exerted	 a	 quite	 obvious	 antinociceptive	
effect	but	weaker	than	that	in	the	previous	(170	mg/kg)	 
group.	The	effect	of	isolated	action	of	morphine	on	the	
TFL	 was	 also	 quite	 significant	 but	 weaker	 than	 that	
in	group	3	 (S. s.	170).	All	blockers	 tested	practically	
completely	 eliminated	 the	 antinociceptive	 effects	 of	
the S. s.	 extract	 in	 the	 optimum	 dose	 (170	 mg/kg).	
Combined	injections	Ond+S. s.	170	and	Scop+S. s.	170	
resulted	 even	 in	 some	 shortening	 of	 the	TFL,	 i.e.,	 in	
some	increase	 in	 the	sensitivity	 to	 thermonociceptive	
stimulation	(Fig.	1).
In	the	writhing	test,	all	doses	of	the	S. s.	extract	used	
in	 isolation	 provided	 very	 intense	 highly	 significant	
antinociceptive	 effects;	 behavioral	 manifestations	
of	 visceral	 pain	 (abdominal	 contractions	 and	
limb	 extensions)	 observed	 within	 the	 test	 period	
demonstrated	manyfold	decreases.	 Isolated	 injections	
of	morphine	 nearly	 completely	 eliminated	 the	 above	
pain	 manifestations	 in	 the	 writhing	 test.	 Combined	
injections	 of	 all	 blockers	 used	 seemed	 to	 exert	
insignificant	 influences	 on	 the	 actions	 of	 the	 S. s.	
extract;	there	were	no	significant	differences	between	
the	drug­injected	groups	and	group	S. s.	170	(Fig.	2).
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DISCUSSION
The	 problem	 of	 finding	 novel	 antinociceptive	 drugs	
with	better	main	positive	effects	and	lesser	side	effects	
remains	extremely	urgent.
Our	 study	 demonstrated that S. s.	 aqueous	 seed	
extract	 can	 exert	 significant	 antinociceptive	 effects.	
As	 we	 can	 see,	 the	 mean	 TFL	 values	 increased	
noticeably	in	the	extract­receiving	groups.	The	levels	
of	antinociception	showed	a	certain	dose	dependence	
in	the	tail­flick	test,	and	a	dose	of	170	mg/kg	of	the	dry	
extract	 appeared	 to	 be	 optimum	 in	 this	 test	 (Fig.	 1).	 
F i g. 1. Effects	of	the	aqueous	extract	of	Securigera securidaca	L.	(S. s.)	on	the	tail­flick	latency	(TFL),	sec.	Light	and	dark	columns	are	the	
mean	TFL	values	±	s.e.m.	before	and	after	injections	of	the	drugs,	respectively.	The	S. s.	extract	was	injected	in	groups	2­4	in	three	different	
doses	indicated	(mg/kg);	in	groups	6­9	it	was	injected	in	the	170	mg/kg	dose	after	preliminary	injections	of	naloxone	(Nal),	ondansetron	
(Ond),	metoclopramid	(Met),	and	scopolamine	(Scop).	Mice	of	the	control	group	1	(Contr.)	and	group	5	(Morph)	were	injected	only	with	
saline	and	morphine,	respectively.	*P	<	0.05,	**P	<	0.01,	and	***P <	0.001	in	comparisons	with	group	1	(Contr.)	using	the	paired	t­test	and	
ANOVA;	one,	two,	and	three	#	symbols,	the	same	in	comparisons	with	group	3	(S. s 170).
Р и с. 1.	Впливи	водного	екстракту	Securigera securidaca на	латентний	період	відсмикування	хвоста	у	відповідному	тесті.
F i g. 2. Effects	of	the	S. s.	extract	in	different	doses	(applied	in	isolation	and	in	combination	with	the	drugs	indicated)	on	the	numbers	of	
pain	behavioral	manifestations	(abdominal	contractions	and	hindlimb	extensions)	in	the	writhing	test.	The	effect	of	isolated	injections	of	
morphine	is	also	shown.	Designations	are	similar	to	those	in	Fig.	1.	
Р и с. 2.	Впливи	екстракту	Securigera securidaca у	різних	дозах,	що	вводився	ізольовано	або	в	комбінації	із	зазначеними	агентами,	
на	кількість	больових	поведінкових	проявів	(корчів	тулуба	та	розгинань	задніх	кінцівок)	у	„корчовому”	тесті.
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Naloxone	and	metoclopramide	reduced	the	TFL	values	
in	 the	 respective	 Nal+S. s.	 170	 and	 Met+S. s.	 170	
groups	with	no	significant	differences	between	the	pre­	
and	 post­injection	 tail­flick	 indices.	 Thus,	 it	 can	 be	
concluded	that	opioidergic	and	dopaminergic	systems	
are	involved	to	a	significant	extent	in	the	effects	of	S. s.	 
on	acute	somatosensory	pain.	Flavonoids	are	known	to	
affect	 pain	 of	 different	 origins	with	 the	 involvement	
of	 the	 opioidergic	 system	 [14],	 and	 the	 respective	
components	 have	 been	 found	 in	 the	S. s.	 extract	 [5].	
Thus,	 	 the	 inhibitory	 action	 of	 naloxone	 on	 opioid	
receptors	might	be	the	reason	for	the	respective	effect,	
but	we	 are	 not	 sure	 if	 elimination	 of	 antinociception	
after	 blocking	 of	 dopamine	 receptors	 is	 related	 to	
flavonoids	 or	 some	 other	 components	 in	 the	 extract.	
It	 is	 interesting	 (and	 even	 strange)	 that	 combined	
injections	 of	 ondancetron	 and	 scopolamine	 with	
the	 extract	 made	 somatosensory	 pain	 more	 intense	
(reduced	 the	 mean	 TFLs),	 showing	 a	 significant	
difference	 in	 comparison	 with	 the	 respective	 values	
before	 injection.	Additional	 studies	 are	 necessary	 to	
find	the	answer	for	this	question.	
In	the	writhing	test,	we	observed	clear	antinocicep­
tive effects	 in	 all	 extract­	 and	 drug­injected	 groups.	
Thus,	the	effects	of	the	S. s.	extract	in	the	case	of	vis­
ceral	pain	differ	noticeably	from	those	in	the	tail­flick	
test	(thermonociception­induced	somatosensory	pain).	
There	 were	 no	 significant	 differences	 between	 the	
drug­injected	groups;	it	seems	that	in	the	case	of	vis­
ceral	 pain	 the	S. s.	 extract	may	affect	 some	different	
afferent	 and	 CNS	 pathways.	 It	 remains	 unclear	 why	
naloxone	 (an	 opioid	 antagonist)	 did	 not	 suppress	 the	
antinociceptive	effect	of	the	extract	under	these	condi­
tions	(in	contrast	to	what	we	observed	in	the	tail­flick	
test).	 Interactions	between	multiple	compounds	pres­
ent	 in	 the	extract	and	 involved	 in	 the	antinociception	
effect	 of	 the	 latter	 and	differences	between	 the	path­
ways	 of	 pain	modulation	 in	 the	 case	 of	 somatic	 and	
visceral	pain	may	be	 reasons	 for	 some	of	 the	contra­
dictions	in	our	observations.
Reduction	 of	 abdominal	 constrictions	 in	 the	
writhing	 test	 was	 found	 after	 the	 pretreatment	
with	 dihydroxyflavones	 [14].	 There	 are	 several	
indications	 pointing	 to	 the	 role	 of	 the	 opioid	
system	 in	 the	 antinociception	 effects of flavonoid 
compounds	 [15­17,	 14]. Also,	 there	 are	 some	 reports	
that	 serotonergic	 pathways	 can	 play	 a	 role	 in	 these	
effects	 of	 flavonoids	 [18].	 It	 was	 demonstrated	 that	
the bioflavonoid	 quercetin	 affects	 the	 dopaminergic	
[19]	and	adrenergic	 [20]	systems	and	decreases	pain.	
At	 the	 same	 time,	 it	 was	 reported	 that	 ondansetron	
(serotonergic	 antagonist),	 haloperidol	 (dopaminergic	
antagonist),	 and	 yohimbine	 (alpha­2	 adrenergic	
receptor	antagonist)	did	not	reverse	the	antinociception	
effects	 of	 flavonoids	 [14].	 Naloxone	 did	 not	 block	
the	 antinociception	 effect	 of	 Polygala paniculata L. 
hydroalcohol	 extract;	 the	 latter	 includes	 a	 flavonoid,	
rutin.	 It	was	 supposed	 that	 the	above	compound	may	
affect	 pain	 only	 synergically	 with	 other	 compounds	
present	 in	 the	 extract	 [21].	 Certain	 relationships	 in	
the	 molecular	 structure	 of	 flavonoids	 and	 opioid	
receptors	 can	 explain	 the	 interaction	 between	 them	
[22].	 Naloxone	 and	 WAY100635	 (a	 selective	 5HT
1A
 
antagonist)	 prevented	 the	 effects	 of	 Rosmarinus 
officinalis extract in	 pain­induced	 functional	
impairment	 in	 the	 rat	 model	 (PIFIR),	 showing	 that	
both	opioidergic	and	serotonergic	systems	play	certain	
roles	in	the	antinociception	effect	of	the	extract	of	this	
plant;	 the	 latter	 contains	 a	 flavone	 glycoside	 called	
hesperidin	[23].	Loscalzo	et	al.	[24]	also	reported	that	
opioid	 receptors	 are	 involved	 in	 the	 antinociceptive	
effect	 of	 hesperidin. It	 should	 be	 recognized	 that	
opinions	 on	 the	 mechanisms	 of	 analgesic	 effects	 of	
flavonoids	have	not	been	finalized.	
Therefore,	our	experiments	demonstrated	that	the	S. s.	 
aqueous	 extract	 exerts	 significant	 antinociception	
effects,	and	flavonoids	present	 in	 this	extract	may	be	
the	main	reason	for	such	an	action.	At	the	same	time,	
results	obtained	with	use	of	the	tail­flick	and	writhing	
tests	 and	 also	 with	 application	 of	 certain	 receptor	
blockers	 are	 controversial	 from	 a	 few	 aspects	 and	
difficult	 to	 interpret.	 Thus,	 additional	 investigations	
are	 needed	 to	 make	 clearer	 the	 mechanisms	 of	
interaction	of	the	components	of	the	examined	extract	
and	their	action	on	the	main	neurochemical	systems.	
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Р	е	з	ю	м	е
Ми	 досліджували	 впливи	 водного	 екстракту	 з	 насіння	 Se-
curigera securidaca L.	(S.	s.)	–	рослини,	що	використовуєть­
ся	в	народній	медицині,	–	на	експериментально	викликаний	
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біль	 у	 мишей	 лінії	 balb­c.	 Застосовували	 тест	 з	 відсмику­
ванням	 хвоста	 (соматичний	 біль,	 викликаний	 термоноци­
цептивною	стимуляцією)	та	«корчовий»	тест	(вісцеральний	
біль	після	внутрішньоочеревинних	уведень	оцтової	кисло­
ти).	Перед	 тестами	 внутрішньоочеревинно	 ін’єкували	 екс­
тракт	 у	 трьох	 дозах	 (85,	 170	 та	 340	 мг	 сухої	 речовини	 на	
1	 кг	 маси	 тіла).	 В	 обох	 тестах	 спостерігали	 істотні	 анти­
ноцицептивні	 впливи	 екстракту;	 доза	 170	 мг/кг	 виглядала	
оптимальною.	 Антиноцицептивні	 впливи	 екстракту	 S. s.	
були	 порівняльними	 з	 такими	 після	 введень	 1	 мг/кг	 мор­
фіну.	Налоксон,	метоклопрамід,	ондацетрон	та	 скополамін	
(антагоністи	опіоїдних,	дофамінових,	серотонінових	та	хо­
лінергічних	 рецепторів	 відповідно)	 повністю	 нівелювали	
антиноцицептивні	ефекти	екстракту	S. s.	у	тесті	відсмику­
вання	хвоста;	 ефекти	 згаданих	антагоністів	у	 „корчовому”	
тесті	не	були	такими	очевидними.	Обговорюються	можли­
ві	 механізми	 аналгетичних	 впливів	 екстракту	 S. s.;	 відпо­
відні	 ефекти	 вірогідно	 залежать	 (у	 всякому	 разі	 частково)	
від	 наявності	 в	 цьому	 екстракті	флавоноїдів.	Для	 адекват­
ної	 інтерпретації	зазначених	механізмів	потрібні	подальші	
дослідження.	  
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